IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q2 2021 Holdings

Filed 2021-08-16 | 15 holdings | $42.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$35.9M432,92684.2%
Argenx SE(ARGX)SPONSORED ADR04016X101$6.4M21,20015.0%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$67.7K1,813,3920.2%
Spero Therapeutics Inc(SPRO)COM84833T103$53.5K3,829,2090.1%
Blueprint Medicines Corp(2L9)COM09627Y109$39.5K448,5120.1%
Uniqure NV(QURE)SHSN90064101$35.7K1,157,5130.1%
Magenta Therapeutics IncCOM55910K108$26.3K2,687,1830.1%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$23.6K1,194,2370.1%
Regenxbio Inc(RGNX)COM75901B107$23.1K595,4440.1%
4D Molecular Therapeutics in(FDMT)COM35104E100$22.8K945,3820.1%
Amryt Pharma PLCSPONSORED ADS03217L106$13.8K1,140,0000.0%
Pieris Pharmaceuticals IncCOM720795103$12.2K3,196,5270.0%
Harpoon Therapeutics IncCOM41358P106$9.9K712,6740.0%
Galapagos NV(GLPG)SPON ADR36315X101$9.8K142,3400.0%
Genmab A/S(GMAB)SPONSORED ADS372303206$4.9K120,0000.0%